Effectiveness of antidepressants in the treatment of major depressive disorder in Latin America

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry 2001; 62(Suppl 16)26–31
   PubMedGoogle Scholar
• Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 1999; 60(Suppl 22)7–11
   PubMedGoogle Scholar
• Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K. Impact of pain on depression treatment response in primary care. Psychosom Med 2004; 66: 17–22
   PubMed Web of Science ®Google Scholar
• Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology 2000; 33: 307–9
   PubMed Web of Science ®Google Scholar
• Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993; 150: 734–41
   PubMed Web of Science ®Google Scholar
• Munoz RA, McBride ME, Brnabic AJ, Lopez CJ, Hetem LA, Secin R, et al. Major depressive disorder in Latin America: The relationship between depression severity, painful somatic symptoms, and quality of life. J Affect Disord 2005; 86: 93–8
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 2003; 60: 39–47
   PubMed Web of Science ®Google Scholar
• Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. New Engl J Med 1999; 341: 1329–35
   PubMed Web of Science ®Google Scholar
• Greco T, Eckert G, Kroenke K. The outcome of physical symptoms with treatment of depression. J Gen Intern Med 2004; 19: 813–8
   PubMed Web of Science ®Google Scholar
• Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, et al. Prevention of relapse in residual depression by cognitive therapy: A controlled trial. Arch Gen Psychiatry 1999; 56: 829–35
   PubMed Web of Science ®Google Scholar
• Gerber PD, Barrett JE, Barrett JA, Oxman TE, Manheimer E, Smith R, et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992; 7: 170–3
   PubMed Web of Science ®Google Scholar
• Burt VK. Plotting the course to remission: The search for better outcomes in the treatment of depression. J Clin Psychiatry 2004; 65(Suppl 12)20–5
   PubMed Web of Science ®Google Scholar
• Thase ME, Rush AJ. Psychopharmacology. The Fourth Generation of Progress. Raven Press, New York 1995
   Google Scholar
• Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 1998; 44: 348–60
   PubMed Web of Science ®Google Scholar
• Schatzberg AF. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. J Clin Psychiatry 2003; 64(Suppl 13)30–7
   PubMed Web of Science ®Google Scholar
• Greden JF. Unmet need: What justifies the search for a new antidepressant?. J Clin Psychiatry 2002; 63(Suppl 2)3–7
   PubMedGoogle Scholar
• McCombs JS, Nichol MB, Stimmel GL, Sclar DA, Beasley CMJr, Gross LS. The cost of antidepressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry 1990; 51(Suppl)60–9
   PubMedGoogle Scholar
• Kessler RC, Barber C, Birnbaum HG, Frank RG, Greenberg PE, Rose RM, et al. Depression in the workplace: Effects on short-term disability. Health Aff (Millwood) 1999; 18: 163–71
   PubMed Web of Science ®Google Scholar
• Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. J Am Med Assoc 2003; 289: 3135–44
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, et al. The economic burden of depression in the United States: How did it change between and 2000?. J Clin Psychiatry 1990; 2003(64)1465–75
   Google Scholar
• Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, et al. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry 2002; 59: 233–9
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV, III, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994; 3: 774–9
   PubMedGoogle Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Guy, W. ECDEU assessment manual for psychopharmacology. Rockville, MD: US Department of Health and Human Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch; 1976.
   Google Scholar
• DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: Intrasubject variability and correlation with a numeric scale. Anesth Analg 1998; 86: 102–6
   PubMed Web of Science ®Google Scholar
• Hunt SM, McKenna SP. The QLDS: A scale for the measurement of quality of life in depression. Health Policy 1992; 22: 307–19
   PubMed Web of Science ®Google Scholar
• Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: Do improvements in these symptoms result in higher remission rates?. J Clin Psychiatry 2004; 65: 521–30
   PubMed Web of Science ®Google Scholar
• Montgomery S, Doyle JJ, Stern L, McBurney CR. Economic considerations in the prescribing of third-generation antidepressants. Pharmacoeconomics 2005; 23: 477–91
   PubMed Web of Science ®Google Scholar
• Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess 2005; 9: 1–148
   PubMed Web of Science ®Google Scholar
• Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, et al. Discontinuation of use and switching of antidepressants: Influence of patient-physician communication. J Am Med Assoc 2002; 288: 1403–9
   PubMed Web of Science ®Google Scholar